États-Unis · Magazines éco · Inc.

SheMed Built a $1 Billion Business on GLP-1s. Its Next Bet Goes Beyond Weight Loss

Publié par Inc. · États-Unis il y a 1 h

SheMed’s study of more than 8,000 women found improvements in weight, blood sugar, and cholesterol. Its founders believe that’s just the start of what GLP-1 research could uncover.

Lire l'article complet sur Inc. Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.inc.com)

SheMed Built a $1 Billion Business on GLP-1s. Its Next Bet Goes Beyond Weight Loss

À lire aussi

Highway thieves have stolen more than $100 million in data center equipment since June

Should You Invest Your Emergency Fund? Investing Your Safety Net Sounds Great, Until You Need It

Samsung Electronics exec: the investments that endure build more than factories

Europe Keeps Exporting Its Best Tech Founders to the U.S. — But Why?

Microsoft offers voluntary buyouts to 60,000 employees as tech giant reshapes its workforce

What early voting data is showing in key Midwestern states

SheMed Built a $1 Billion Business on GLP-1s. Its Next Bet Goes Beyond Weight Loss

Partager

À lire aussi

Highway thieves have stolen more than $100 million in data center equipment since June

Should You Invest Your Emergency Fund? Investing Your Safety Net Sounds Great, Until You Need It

Samsung Electronics exec: the investments that endure build more than factories

Europe Keeps Exporting Its Best Tech Founders to the U.S. — But Why?

Microsoft offers voluntary buyouts to 60,000 employees as tech giant reshapes its workforce

What early voting data is showing in key Midwestern states